Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New therapies towards a better glycemic control in youths with type 1 diabetes.
Cardona-Hernandez R, Dôvc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, Mameli C. Cardona-Hernandez R, et al. Among authors: biester t. Pharmacol Res. 2023 Sep;195:106882. doi: 10.1016/j.phrs.2023.106882. Epub 2023 Aug 3. Pharmacol Res. 2023. PMID: 37543096 Free PMC article. Review.
[Attaching an Insulin Pump].
Biester T, Biester S, Kordonouri O, Danne T. Biester T, et al. Among authors: biester s. Dtsch Med Wochenschr. 2017 May;142(10):758-762. doi: 10.1055/s-0042-119235. Epub 2017 May 17. Dtsch Med Wochenschr. 2017. PMID: 28514824 German. No abstract available.
[The Way to Closed Loop - Dream and Reality].
Biester T, Danne T, Kordonouri O. Biester T, et al. Dtsch Med Wochenschr. 2017 May;142(10):731-736. doi: 10.1055/s-0042-119492. Epub 2017 May 17. Dtsch Med Wochenschr. 2017. PMID: 28514821 German.
Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.
Dovc K, Macedoni M, Bratina N, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T. Dovc K, et al. Among authors: biester t. Diabetologia. 2017 Nov;60(11):2157-2167. doi: 10.1007/s00125-017-4395-z. Epub 2017 Aug 24. Diabetologia. 2017. PMID: 28840263 Free PMC article. Clinical Trial.
Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.
Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M. Nimri R, et al. Among authors: biester t. Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18. Diabetes Obes Metab. 2018. PMID: 29885025 Free article.
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R. Biester T, et al. Among authors: biester s. Diabetes Obes Metab. 2019 Apr;21(4):822-828. doi: 10.1111/dom.13585. Epub 2018 Dec 21. Diabetes Obes Metab. 2019. PMID: 30478937 Clinical Trial.
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Battelino T, et al. Among authors: biester t. Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Diabetes Care. 2019. PMID: 31177185 Free PMC article. Review.
Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Dovc K, Piona C, Yeşiltepe Mutlu G, Bratina N, Jenko Bizjan B, Lepej D, Nimri R, Atlas E, Muller I, Kordonouri O, Biester T, Danne T, Phillip M, Battelino T. Dovc K, et al. Among authors: biester t. Diabetes Care. 2020 Jan;43(1):29-36. doi: 10.2337/dc19-0895. Epub 2019 Oct 1. Diabetes Care. 2020. PMID: 31575640 Clinical Trial.
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
Biester T, Muller I, von dem Berge T, Atlas E, Nimri R, Phillip M, Battelino T, Bratina N, Dovc K, Scheerer MF, Kordonouri O, Danne T. Biester T, et al. Diabetes Obes Metab. 2021 Feb;23(2):599-608. doi: 10.1111/dom.14258. Epub 2020 Dec 10. Diabetes Obes Metab. 2021. PMID: 33217117 Clinical Trial.
100 results